My point was that the weaknesses identified (after the product strengths) were not weaknesses in the product but shareholder risks in commercialising the chip. The product IP has already been commercialised - so the product does exist.
Technology due diligence, page-110
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.025(9.80%) |
Mkt cap ! $451.3M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 22.0¢ | $3.918M | 16.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 658476 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 112520 | 8 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| BRN (ASX) Chart |